IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr. William G. Kaelin Jr. to its board of ...
Phase 1 dose escalation trial in SMARCA4 (BRG1)-mutated cancer remains on track with non-small cell lung cancer ...
Konyushkov is an intriguing prospect. While the stat line isn’t the best with regard to points, he still logs around 22 minutes a night for Torpedo, the second-ranked team in the western conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback